SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001246360-12-004368
Filing Date
2012-11-09
Accepted
2012-11-09 09:15:11
Documents
1
Period of Report
2012-10-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form.html 3  
1 PRIMARY DOCUMENT form.xml 3 2906
  Complete submission text file 0001246360-12-004368.txt   4357
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1380 WILLOW ROAD MENLO PARK CA 94025
Business Address
Glynn Michael (Reporting) CIK: 0001528924 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23155 | Film No.: 121191881